Evidence map›Paper›PMID 27601673›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2016

SCAP/SREBP pathway is required for the full steroidogenic response to cyclic AMP.

Masami Shimizu-Albergine, Brian Van Yserloo, Martin G Golkowski, Shao-En Ong, Joseph A Beavo, Karin E Bornfeldt

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
4.1field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 49 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. The Role of PDE8 in T Cell Recruitment and Function in Inflammation.Frontiers in cell and developmental biology · 2021
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Masami Shimizu-AlbergineSchool of Medicine, Department of Pharmacology, University of Washington, Seattle, WA 98195; School of Medicine, Department of Medicine, Division of Metabolism, Endocrinology and Nutrition, University of Washington, Seattle, WA 98109; University of Washington Diabetes Institute, School of Medicine, University of Washington, Seattle, WA 98109;
Brian Van YserlooSchool of Medicine, Department of Medicine, Division of Metabolism, Endocrinology and Nutrition, University of Washington, Seattle, WA 98109; University of Washington Diabetes Institute, School of Medicine, University of Washington, Seattle, WA 98109;
Martin G GolkowskiSchool of Medicine, Department of Pharmacology, University of Washington, Seattle, WA 98195;
Shao-En OngSchool of Medicine, Department of Pharmacology, University of Washington, Seattle, WA 98195;
Joseph A BeavoSchool of Medicine, Department of Pharmacology, University of Washington, Seattle, WA 98195; beavo@uw.edu bornf@uw.edu.
Karin E BornfeldtSchool of Medicine, Department of Medicine, Division of Metabolism, Endocrinology and Nutrition, University of Washington, Seattle, WA 98109; University of Washington Diabetes Institute, School of Medicine, University of Washington, Seattle, WA 98109; School of Medicine, Department of Pathology, University of Washington Diabetes Institute, University of Washington, Seattle, WA 98109 beavo@uw.edu bornf@uw.edu.
University of Washington · US

Funding

Vector and Transgenic Mouse CoreP30DK017047 · NIDDK · UNIVERSITY OF WASHINGTON · PI Sakeneh Zraika · 1986 to 2026
$41.4M
Role of Serum Amyloid A in Diabetic Vascular DiseaseP01HL092969 · NHLBI · UNIVERSITY OF WASHINGTON · PI BORNFELDT, KARIN E. · 2008 to 2019
$23.5M
HYPERGLYCEMIA, PROTEIN KINASES AND SMOOTH MUSCLE GROWTHR01HL062887 · NHLBI · UNIVERSITY OF WASHINGTON · PI BORNFELDT, KARIN E. · 1998 to 2014
$4.7M
Regulation of Cellular Functions by Cyclic Nucleotide Phosphodiesterase 8R01GM083926 · NIGMS · UNIVERSITY OF WASHINGTON · PI BEAVO, JOSEPH A · 2008 to 2015
$3.0M
Obesity and Arterial MetabolismR01HL126028 · NHLBI · UNIVERSITY OF WASHINGTON · PI BORNFELDT, KARIN E. · 2015 to 2018
$1.7M
Leica SP8 WWL Confocal MicroscopeS10OD016240 · OD · UNIVERSITY OF WASHINGTON · PI CATTERALL, WILLIAM A · 2014 to 2014
$581k
NHLBI NIH HHS P01 HL092969NHLBI NIH HHS R01 HL062887NHLBI NIH HHS R01 HL126028NIDDK NIH HHS P30 DK017047NIGMS NIH HHS R01 GM083926NIH HHS S10 OD016240
6 · The paper itself

Abstract

Luteinizing hormone (LH) stimulates steroidogenesis largely through a surge in cyclic AMP (cAMP). Steroidogenic rates are also critically dependent on the availability of cholesterol at mitochondrial sites of synthesis. This cholesterol is provided by cellular uptake of lipoproteins, mobilization of intracellular lipid, and de novo synthesis. Whether and how these pathways are coordinated by cAMP are poorly understood. Recent phosphoproteomic analyses of cAMP-dependent phosphorylation sites in MA10 Leydig cells suggested that cAMP regulates multiple steps in these processes, including activation of the SCAP/SREBP pathway. SCAP [sterol-regulatory element-binding protein (SREBP) cleavage-activating protein] acts as a cholesterol sensor responsible for regulating intracellular cholesterol balance. Its role in cAMP-mediated control of steroidogenesis has not been explored. We used two CRISPR (clustered regularly interspaced short palindromic repeat)-Cas9 (CRISPR associated protein 9) knockout approaches to test the role of SCAP in steroidogenesis. Our results demonstrate that SCAP is required for progesterone production induced by concurrent inhibition of the cAMP phosphodiesterases PDE4 and PDE8. These inhibitors increased SCAP phosphorylation, SREBP2 activation, and subsequent expression of cholesterol biosynthetic genes, whereas SCAP deficiency largely prevented these effects. Reexpression of SCAP in SCAP-deficient cells restored SREBP2 protein expression and partially restored steroidogenic responses, confirming the requirement of SCAP-SREBP2 in steroidogenesis. Inhibitors of 3-hydroxy-3-methylglutaryl-Coenzyme A reductase and isoprenylation attenuated, whereas exogenously provided cholesterol augmented, PDE inhibitor-induced steroidogenesis, suggesting that the cholesterol substrate needed for steroidogenesis is provided by both de novo synthesis and isoprenylation-dependent mechanisms. Overall, these results demonstrate a novel role for LH/cAMP in SCAP/SREBP activation and subsequent regulation of steroidogenesis.

Indexed as

AnimalsCarrier ProteinsCholesterolCyclic AMPGene Expression RegulationHydroxymethylglutaryl CoA ReductasesIntracellular Signaling Peptides and ProteinsLeydig CellsLipoproteinsLuteinizing HormoneMaleMembrane ProteinsMitochondriaPhosphorylationSteroidsSterol Regulatory Element Binding Protein 2Carrier ProteinsCholesterolCyclic AMPHydroxymethylglutaryl CoA ReductasesIntracellular Signaling Peptides and ProteinsLipoproteinsLuteinizing HormoneMembrane ProteinsSREBP cleavage-activating proteinSteroidsSterol Regulatory Element Binding Protein 2cAMPcholesterolphosphodiesteraseSCAP/SREBPsteroidogenesis

Identifiers

PMID27601673
PMCPMC5035853
OpenAlexW2510543718

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.